Skip to content

Psychiatry and Clinical Neurosciences

ISSN 1323-1316, 1440-1819

50 papers in the library · 939 citations · publishing 1953-2026

Papers

Sort Most recent Most cited

Hitting and missing on consciousness

Psychiatry and Clinical Neurosciences September 17, 2026 T Nakamura, Matthias Michel, Hakwan Lau

Disturbances of conscious experience are central features of many psychiatric and mental health disorders. Experimental studies of conscious perception are therefore increasingly cited in clinical and translational work under the assumption that they identify neural mechanisms specific to subjective experience. Over the past decades, recording and analysis techniques have advanced substantially...

Brain Network Convergence of Abnormal Gray Matter and Functional Activity of Pathological Dissociative Symptoms.

Psychiatry and Clinical Neurosciences August 29, 2026 Xuhan Cui, Leyi Zhang, Y. Ou et al.

AIM Pathological dissociation is a complex clinical symptom widely observed across various psychiatric disorders. Dissociative symptoms prolong the duration of hospitalization and are associated with a poor clinical prognosis. Although several pathological models (e.g., the frontal-limbic overmodulation model and the defense cascade model) have been proposed to interpret dissociative symptoms,...

Safety and tolerance of oral ketamine: A systematic review.

Psychiatry and Clinical Neurosciences May 30, 2026 Nathalia Novaretti, Rebeca Mendes P Pessoa, Jaime Eduardo Cecilio Hallak et al.

Oral ketamine has gained increasing interest beyond anesthesia, particularly for treatment-resistant depression, chronic pain, and pediatric procedural sedation. Despite expanding off-label use, there is no standardized pharmaceutical formulation, and long-term safety remains uncertain. A synthesis of evidence on safety and tolerability of the oral route is therefore needed to inform clinical...

Disturbing dreams and dementia risk across diverse populations

Psychiatry and Clinical Neurosciences May 7, 2026 Abidemi I Otaiku

While the relationship between bad dreams, nightmares, and brain health is a relatively new area of research, the evidence to date has been remarkably consistent. Across a range of studies, including both cross-sectional and longitudinal designs, the emerging pattern is clear: more frequent disturbing dreams (bad dreams or nightmares) are linked with poorer cognitive performance and a higher...

DOI: 10.1111/pcn.70074 (opens in new tab) Dementia Generalizability theory Cognition Lewy body +6

Disturbing dreams and dementia incidence across diverse cohort studies: A COSMIC collaboration study

Psychiatry and Clinical Neurosciences March 17, 2026 Darren M. Lipnicki, Ashleigh S. Vella, É. Castro-Costa et al.

Distressing dreams were previously reported to predict future all‐cause dementia among predominantly white US participants aged 79–89 years, particularly in men. We investigated whether disturbing dreams (nightmares and bad dreams) were associated with all‐cause and Alzheimer dementia (AD) among individuals aged 60–89 years from diverse international regions.

Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations

Psychiatry and Clinical Neurosciences February 26, 2026 Kengo Yonezawa, Mika Hirata, Hiroaki Takano et al. 1 citation

Psilocybin, a classic psychedelic compound, has garnered renewed interest as a potential treatment for various psychiatric disorders. This review provides a comprehensive overview of psilocybin's history, recent clinical evidence, ongoing clinical trials, neuroimaging findings, and regulations. Historically used in spiritual and healing rituals, psilocybin was in the early 1970s subjected to...

Physiological markers of Trauma-related nightmares among military personnel suffering from PTSD: A multicenter home-recording study.

Psychiatry and Clinical Neurosciences February 14, 2026

Aim: Despite being one of the most disabling symptoms of post‐traumatic stress disorder (PTSD)—disrupting sleep continuity, reinforcing hyperarousal, and worsening psychiatric comorbidity—the physiological signature of Trauma‐related nightmares (TRNs) under naturalistic sleep conditions remains poorly characterized. Methods: We used home‐based, multi‐sensor devices from the SOMMEPT cohort to...

Acute and long-term effects of repeated ketamine infusions in treatment-resistant depression and associated metabolite changes.

Psychiatry and Clinical Neurosciences July 15, 2025 Hitoshi Sakurai, Daiki Setoyama, Takahiro A Kato et al. 1 citation

This study aims to investigate the acute and sustained antidepressant effects of repeated ketamine infusions in patients with treatment-resistant depression (TRD), and to identify early metabolomic changes predictive of treatment outcomes using metabolome analyses. This open-label study investigated the effects of four intravenous ketamine infusions (0.5 mg/kg) administered over 2 weeks in 30...

DOI: 10.1111/pcn.13870 (opens in new tab) Full text (opens in new tab) Ketamine 3‐hydroxybutyrate Metabolomics Treatment‐resistant depression +3

Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.

Psychiatry and Clinical Neurosciences December 1, 2024 Yohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi et al. 13 citations

Although the antidepressant effect of ketamine on treatment-resistant depression (TRD) has been frequently reported in North American and European countries, evidence is scarce among the Asian population. We aimed to evaluate the efficacy and safety of intravenous ketamine in Japanese patients with TRD. In this double-blind randomized placebo-controlled trial, 34 Japanese patients with TRD were...

Impact of psilocybin on cognitive function: A systematic review

Psychiatry and Clinical Neurosciences October 1, 2024 Shakila Meshkat, Fatemeh Gholaminezhad, Eric Vermetten et al. 24 citations

Psilocybin is a classic psychedelic with demonstrated preliminary clinical efficacy in a range of psychiatric disorders. Evaluating the impact of psilocybin on cognitive function is essential to unravel its potential benefits and risks. In this systematic review, we assessed psilocybin's effect on cognitive function through a comprehensive search of electronic databases from inception to...

DOI: 10.1111/pcn.13741 (opens in new tab) Psilocybin Cognition Empathy Cognitive flexibility +6

Associations between self‐reported parasomnias and psychiatric illness in 370,000 patients with sleep disorders

Psychiatry and Clinical Neurosciences August 30, 2024 Umaer Hanif, Alyssa Cairns, Vincent Mysliwiec et al. 14 citations

AIM: To assess self-reported parasomnias in patients with sleep disorders and explore relationships with psychiatric illness, comorbidities, subjective sleep assessments, and polysomnographic study results. METHODS: Results from intake questionnaires and polysomnographic assessments, collected from 240 sleep centers across 30 US states between 2004 and 2019, were analyzed retrospectively. Of...

Metacognition as a window into subjective affective experience

Psychiatry and Clinical Neurosciences June 17, 2024 Cody A Cushing, Ha-Kwan Lau, Stefan G Hofmann et al.

When patients seek professional help for mental disorders, they often do so because of troubling subjective affective experiences. While these subjective states are at the center of the patient's symptomatology, scientific tools for studying them and their cognitive antecedents are limited. Here, we explore the use of concepts and analytic tools from the science of consciousness, a field of...

Impact of a mindfulness‐based intervention on neurobehavioral functioning and its association with large‐scale brain networks in preterm young adolescents

Psychiatry and Clinical Neurosciences May 17, 2024 Vanessa Siffredi, Maria Chiara Liverani, Natalia B. Fernandez et al. 2 citations

AIM: Adolescents born very preterm (VPT; <32 weeks of gestation) face an elevated risk of executive, behavioral, and socioemotional difficulties. Evidence suggests beneficial effects of mindfulness-based intervention (MBI) on these abilities. This study seeks to investigate the association between the effects of MBI on executive, behavioral, and socioemotional functioning and reliable changes...

DOI: 10.1111/pcn.13675 (opens in new tab) Mindfulness Socioemotional selectivity theory Coactivation Association psychology +6

Eight-month intensive meditation-based intervention improves refractory hallucinations and delusions and quality of life in male inpatients with schizophrenia: a randomized controlled trial.

Psychiatry and Clinical Neurosciences April 1, 2024 Ting Xue, Jialing Sheng, Hui Gao et al. 5 citations

This study investigated the impact of an 8-month daily-guided intensive meditation-based intervention (iMI) on persistent hallucinations/delusions and health-related quality of life (QoL) in male inpatients with schizophrenia with treatment-refractory hallucinations and delusions (TRHDs). A randomized controlled trial assigned 64 male inpatients with schizophrenia and TRHD equally to an 8-month...

DOI: 10.1111/pcn.13641 (opens in new tab) Full text (opens in new tab) Meditation‐based intervention Quality of life Randomized controlled trial Schizophrenia

Associations of conservatism and jumping to conclusions biases with aberrant salience and default mode network

Psychiatry and Clinical Neurosciences February 27, 2024 Jun Miyata, Akihiko Sasamoto, Takahiro Ezaki et al.

While conservatism bias refers to the human need for more evidence for decision‐making than rational thinking expects, the jumping to conclusions (JTC) bias refers to the need for less evidence among individuals with schizophrenia/delusion compared to healthy people. Although the hippocampus‐midbrain‐striatal aberrant salience system and the salience, default mode (DMN), and frontoparietal...

Long-term benefits of mindfulness on white matter tracts underlying the cortical midline structures in panic disorder: A 2-year longitudinal study.

Psychiatry and Clinical Neurosciences June 2023 Minji Bang, Borah Kim, Kang Soo Lee et al.

We aimed to examine the long-term benefits of mindfulness-based cognitive therapy (MBCT) on white matter plasticity in the cortical midline structures (CMS) for a period of 2 years in patients with panic disorder and the relationships between white matter changes in the CMS and severity of state and trait symptoms. Seventy-one participants were enrolled and underwent diffusion tensor imaging at...

Self‐disorder explained: Yasunaga's “Phantom Space Theory” on schizophrenia

Psychiatry and Clinical Neurosciences April 27, 2023 Tsutomu Kumazaki, Naoki Hayashi

Abstract The present article revisits the theoretical model of schizophrenia by Hiroshi YASUNAGA (1929–2011). Yasunaga restated ego disturbance in schizophrenia as the “Pattern Reversal” between selfhood and otherness, based on British philosopher Wauchope's concept of “pattern.” This concept is meant as asymmetrical relatedness (A/B) within a pair of concepts, such as life and death, quality...

Influence of cannabis use on incidence of psychosis in people at clinical high risk

Psychiatry and Clinical Neurosciences April 18, 2023 Lucy Chester, Lucia Valmaggia, Matthew J. Kempton et al.

Evidence for case–control studies suggests that cannabis use is a risk factor for the development of psychosis. However, there have been limited prospective studies and the direction of this association remains controversial. The primary aim of the present study was to examine the association between cannabis use and the incidence of psychotic disorders in people at clinical high risk of...

Effectiveness of mindfulness‐based cognitive therapy in patients with anxiety disorders in secondary‐care settings: A randomized controlled trial

Psychiatry and Clinical Neurosciences November 27, 2019 Akira Ninomiya, Mitsuhiro Sado, Sunre Park et al.

The primary objective of this study was to examine the effectiveness of mindfulness‐based cognitive therapy (MBCT) in secondary‐care settings where the vast majority of the patients have already undergone pharmacotherapy but have not remitted.

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective

Psychiatry and Clinical Neurosciences June 19, 2019 Kenji Hashimoto 325 citations

Major depressive disorder (MDD) is one of the most disabling psychiatric disorders. Approximately one‐third of the patients with MDD are treatment resistant to the current antidepressants. There is also a significant therapeutic time lag of weeks to months. Furthermore, depression in patients with bipolar disorder (BD) is typically poorly responsive to antidepressants. Therefore, there exists...

Time until relapse after augmentation with single‐dose ketamine in treatment‐resistant depression

Psychiatry and Clinical Neurosciences June 19, 2018 R. Pérez-Esparza, T. Corona, R. Ruiz-García et al.

Growing evidence of the rapid antidepressant effects of ketamine represents a promising advance in treatment-resistant depression (TRD) therapeutics. Most studies provide information after treatment washout, reporting response up to 7 days and remission up to 3-5 days after a single dose.

Waking-hour cerebral activations in nightmare disorder: A resting-state functional magnetic resonance imaging study.

Psychiatry and Clinical Neurosciences December 1, 2016 Chanchan Shen, Jiawei Wang, Guorong Ma et al.

The purpose of the current study was to explore the cerebral areas involved in nightmare disorder. Fifteen nightmare disorder patients and 15 healthy volunteers were invited to undergo resting-state functional magnetic resonance imaging and to complete the Nightmare Experience Questionnaire. The nightmare disorder patients scored higher on the Physical Effect and Horrible Stimulation scales,...

DOI: 10.1111/pcn.12455 (opens in new tab) Full text (opens in new tab) Nightmare Anterior cingulate cortex Emotion Hypervigilance +1

Dissociative trance and spirit possession: Challenges for cultures in transition.

Psychiatry and Clinical Neurosciences September 18, 2016 Vishal Bhavsar, Antonio Ventriglio, Dinesh Bhugra 49 citations

The cross-cultural validity of dissociative possession and trance disorders is a matter of some debate, limiting research and meaningful interpretation of prevalence data. Intimate to these concerns is the status of spirit possession categories studied in the social sciences, particularly anthropology. These two categories are phenomenologically related and display similar epidemiological...

Sleep paralysis in adolescents: the 'a dead body climbed on top of me' phenomenon in Mexico.

Psychiatry and Clinical Neurosciences August 1, 2009 Alejandro Jiménez-Genchi, Víctor M Avila-Rodríguez, Frida Sánchez-Rojas et al.

The aim of the present study was to evaluate the prevalence and characteristics of sleep paralysis in adolescents using a folk expression. Three hundred and twenty-two adolescents (mean age, 15.9 +/- 0.88 years; 66.8% female) from three high schools in Mexico City completed both a self-reported questionnaire, including a colloquial definition of sleep paralysis and the Epworth Sleepiness Scale....

Reliability and validity of a Japanese version of the Cambridge depersonalization scale as a screening instrument for depersonalization disorder

Psychiatry and Clinical Neurosciences June 1, 2009 Miyuki Sugiura, Masataka Hirosawa, Sumio Tanaka et al.

Aims: The Cambridge Depersonalization Scale (CDS) is an instrument that has obtained reliability and validity in some countries for use in detecting depersonalization disorder under clinical conditions, but not yet in Japan under non‐psychiatric conditions. The purposes of this study were to develop a Japanese version of the CDS (J‐CDS) and to examine its reliability and validity as an...